3P Biopharmaceuticals makes a significant donation to help Ukraine

3P Biopharmaceuticals, a leading organization specializing in the development of cGMP processes and manufacturing of biological products (CDMO) makes financial and material donations to help Ukraine.

 3P Biopharmaceuticals, a leading organization specializing in the development of cGMP processes and manufacturing of biological products (CDMO) makes financial and material donations to help Ukraine.

3P Biopharmaceuticals makes a significant donation to help Ukraine

3P has a characteristic that few companies in our region have: a workforce made up of 21 different nationalities that work together to develop new medicines. Americans, Argentines, Cubans, Peruvians, Nicaraguans, Mexicans, Italians, Pakistanis, French, Finnish, Lithuanians and Venezuelans. Forming a multicultural workforce that 3P considers a key asset for success as a reference company in Europe, developing and manufacturing biological drugs.

After the start of the war, at the initiative of its employees, the company has activated a support plan for Ukraine through the mobilization and organization of a monetary donation campaign in collaboration with the Spanish Red Cross. The management committee supported this fundraising effort, which matched the employees’ donations equally.

At 3P we are shocked by the attack on freedom and democracy that threatens peace and security in our continent, and we are also proud of the involvement of our employees in this matter. We could not act otherwise, because saving lives is in our DNA. We help with science to advance and treat diseases that currently have no cure and we strive every day to prolong life, ” comments Dámaso Molero, CEO of 3P.

In parallel, Laura Pina, a nurse at 3P, travelled to Poland to help refugees from Ukraine. She left Tafalla on Monday, March 14, and is already on the ground helping the refugees.

The trip was very long, but being a health worker, I feel more useful here, helping not only the war-wounded and sick people who have had to move and need primary care,” explains Laura.

The company has collaborated with her initiative by purchasing material valued at 1,000 euros, including blood pressure monitors, thermometers, pulse oximeters and first aid material, treatments and hygiene products to care for children and babies suffering from this war. She intends to carry out her work for at least two weeks on the border between Poland and Ukraine.

View the full press release here

Our dedicated team of specialists will be happy to discuss any of your CDMO supply chain needs. Contact us on +34 948 346 480 or email withinus@3pbio.com

Related Content

3P Biopharmaceuticals among the 500 fastest growing companies in Spain

Published: 19th December 2022
This is the first year the company appears in the ranking established by CEPYME for 500 companies that lead business growth in Spain.
Read more

3P Biopharmaceuticals brings together leading international experts in biomedicine to celebrate its 15th anniversary.

Published: 1st December 2022
The event gathered an audience of more than 150 people and was attended by Juan Cruz Cigudosa, Councillor for University, Innovation, and Digital Transformation.
Read more

BrainEver and 3P Biopharmaceuticals collaborate on development of recombinant human homeoprotein Engrailed-1

Published: 15th November 2022
3P Bio will focus on the transfer of the production process as well as the cGMP manufacturing of the drug substance to be used in Phase I and II clinical trials. The novel drug could cure neurodegenerative diseases such as Amyotrophic Lateral Sclerosis.
Read more

Get in touch

Let’s discuss your biologics journey.

Discover more about our people, our passion, and how we can work together to improve lives.